Terms: = Breast cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Treatment
233 results:
1. Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic breast cancer Treated With Abemaciclib: Data From the SCRUM-Japan cancer Genome Screening Project.
Hattori M; Serelli-Lee V; Naito Y; Yamanaka T; Yasojima H; Nakamura R; Fujisawa T; Imai M; Nakamura Y; Bando H; Kawaguchi T; Yoshino T; Iwata H
JCO Precis Oncol; 2024 Apr; 8():e2300647. PubMed ID: 38635933
[TBL] [Abstract] [Full Text] [Related]
2. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.
Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive Transcriptomic Analysis of EWSR1::WT1 Targets Identifies CDK4/6 Inhibitors as an Effective Therapy for Desmoplastic Small Round Cell Tumors.
Magrath JW; Sampath SS; Flinchum DA; Hartono AB; Goldberg IN; Boehling JR; Savkovic SD; Lee SB
Cancer Res; 2024 May; 84(9):1426-1442. PubMed ID: 38588409
[TBL] [Abstract] [Full Text] [Related]
4. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
6. Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology.
Li M; Zhao Y; Li H; Kang S; Deng X; Sheng M
Aging (Albany NY); 2024 Feb; 16(3):2848-2865. PubMed ID: 38329441
[TBL] [Abstract] [Full Text] [Related]
7. Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-breast cancer Registry.
Iwamoto T; Kumamaru H; Niikura N; Sagara Y; Miyashita M; Konishi T; Sanuki N; Tanakura K; Nagahashi M; Hayashi N; Yoshida M; Watanabe C; Kinukawa N; Toi M; Saji S
Breast Cancer; 2024 Mar; 31(2):185-194. PubMed ID: 38319565
[TBL] [Abstract] [Full Text] [Related]
8. Anti-breast cancer activity of biosynthesized selenium nanoparticles using Bacillus coagulans supernatant.
Khaledizade E; Tafvizi F; Jafari P
J Trace Elem Med Biol; 2024 Mar; 82():127357. PubMed ID: 38103517
[TBL] [Abstract] [Full Text] [Related]
9. Troponin T1 silencing inhibits paclitaxel resistance and the development of breast cancer via suppressing rat sarcoma virus/rapidly accelerated fibrosarcoma 1 pathway.
Zhu T; Zhou P; Yang L; Fang X; Zhi X
Environ Toxicol; 2024 Apr; 39(4):2064-2076. PubMed ID: 38095131
[TBL] [Abstract] [Full Text] [Related]
10. Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.
Liu Q; Cao Y; Wei X; Dong H; Cui M; Guan S; Liu B; Wang X; Xing P
Cell Death Dis; 2023 Dec; 14(12):803. PubMed ID: 38062011
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast cancer.
Landén AH; Chin K; Kovács A; Holmberg E; Molnar E; Stenmark Tullberg A; Wärnberg F; Karlsson P
Acta Oncol; 2023 Dec; 62(12):1862-1872. PubMed ID: 37934084
[TBL] [Abstract] [Full Text] [Related]
12. Piper chaba, an Indian spice plant extract, inhibits cell cycle G1/S phase transition and induces intrinsic apoptotic pathway in luminal breast cancer cells.
Prajapati KS; Kumar S
Cell Biochem Funct; 2023 Dec; 41(8):1230-1241. PubMed ID: 37711079
[TBL] [Abstract] [Full Text] [Related]
13. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel.
Rasoolnezhad M; Safaralizadeh R; Hosseinpour Feizi MA; Banan-Khojasteh SM; Roshani Asl E; Lotfinejad P; Baradaran B
Mol Biol Rep; 2023 Oct; 50(10):8407-8420. PubMed ID: 37620737
[TBL] [Abstract] [Full Text] [Related]
14. The cost-effectiveness analysis of maintenance olaparib plus Bevacizumab in patients with advanced ovarian cancer: based on the final survival results from PAOLA-1 trial.
Zhu Y; Liu K; Cao H; Zhu H
J Ovarian Res; 2023 Aug; 16(1):168. PubMed ID: 37605274
[TBL] [Abstract] [Full Text] [Related]
15. FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway.
Chen G; Sun L; Gu X; Ai L; Yang J; Zhang Z; Hou P; Wang Y; Ou X; Jiang X; Qiao X; Ma Q; Niu N; Xue J; Zhang H; Yang Y; Liu C
Sci China Life Sci; 2023 Dec; 66(12):2805-2817. PubMed ID: 37460715
[TBL] [Abstract] [Full Text] [Related]
16. Fabrication, optimization, and characterization of pH-responsive PEGylated nanoniosomes containing gingerol for enhanced treatment of breast cancer.
Asghari Lalami Z; Tafvizi F; Naseh V; Salehipour M
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3867-3886. PubMed ID: 37368028
[TBL] [Abstract] [Full Text] [Related]
17. AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced breast cancer.
Tolaney SM; Chan A; Petrakova K; Delaloge S; Campone M; Iwata H; Peddi PF; Kaufman PA; De Kermadec E; Liu Q; Cohen P; Paux G; Wang L; Ternès N; Boitier E; Im SA
J Clin Oncol; 2023 Aug; 41(24):4014-4024. PubMed ID: 37348019
[TBL] [Abstract] [Full Text] [Related]
18. CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway.
Yang S; Peng LR; Yu AQ; Li J
Ann Hepatol; 2023; 28(5):101118. PubMed ID: 37268061
[TBL] [Abstract] [Full Text] [Related]
19. ERα-associated translocations underlie oncogene amplifications in breast cancer.
Lee JJ; Jung YL; Cheong TC; Espejo Valle-Inclan J; Chu C; Gulhan DC; Ljungström V; Jin H; Viswanadham VV; Watson EV; Cortés-Ciriano I; Elledge SJ; Chiarle R; Pellman D; Park PJ
Nature; 2023 Jun; 618(7967):1024-1032. PubMed ID: 37198482
[TBL] [Abstract] [Full Text] [Related]
20. Ethyl acetate extract of Antenoron Filiforme inhibits the proliferation of triple negative breast cancer cells via suppressing Skp2/p21 signaling axis.
Liao Y; Li S; An J; Yu X; Tan X; Gui Y; Wang Y; Huang L; Zhou S; Wang D
Phytomedicine; 2023 Jul; 116():154856. PubMed ID: 37187035
[TBL] [Abstract] [Full Text] [Related]
[Next]
